NCT00531245View on ClinicalTrials.gov

A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

March 31, 2009

Conditions
Colorectal Neoplasms
Interventions
DRUG

TS-1, oxaliplatin

Oxaliplatin(130 mg/m2) day 1, intravenously TS-1 at a dose of 60, 70, 80, 90, 100, 110, 120 mg/m2 given orally starting day 1 until day 14(2 weeks ON, 1 weeks OFF), every 3 weeks

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT00531245 - A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter